Aclaris Therapeutis (ACRS) PT Raised to $50 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ACRS Hot Sheet
Price: $5.26 -8.04%
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
15 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $50.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print
- Ormat Technologies (ORA) PT Lowered to $104 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
